NSC |
Compound |
Enrichment |
Correlation |
NSC 694509 |
Null |
0.0237269271456697 |
0.37027712 |
NSC 697535 |
Null |
0.0237269271456697 |
0.2836863 |
NSC 706992 |
Null |
0.0237269271456697 |
-0.022672292 |
NSC 726217 |
Combretastatin A4-analogue |
0.0237269271456697 |
0.21154232 |
NSC 728078 |
2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide |
0.0237269271456697 |
0.3378908 |
NSC 732936 |
5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0237269271456697 |
0.25039541 |
NSC 732962 |
5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone |
0.0237269271456697 |
0.30628377 |
NSC 733476 |
Null |
0.0237269271456697 |
0.062043139 |
NSC 734949 |
4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide |
0.0237269271456697 |
0.2309272 |
NSC 735472 |
(2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol |
0.0237269271456697 |
0.063529089 |